Strategies for MSC expansion and MSC-based microtissue for bone regeneration

Area of Science:

• Regenerative Medicine
• Biotechnology
• Orthopedics

Background:

• Mesenchymal stem cells (MSCs) are investigated for bone injury treatment due to differentiation and homing capabilities.
• Clinical translation is limited by insufficient cell numbers and incomplete understanding of MSC behavior in different microenvironments.
• Scalable biomanufacturing of therapeutically qualified MSCs is crucial for clinical application.

Purpose of the Study:

• To review MSC features for optimizing regenerative capacity in bone repair.
• To discuss current MSC implantation strategies for bone diseases.
• To explore advancements in large-scale MSC expansion for clinical use.

Main Methods:

• Review of existing literature on MSC biology and therapeutic applications.
• Analysis of various in vitro and in vivo culture methods for MSC expansion.
• Examination of bioreactor technologies, biomaterial platforms, and microtissue strategies for MSC biomanufacturing.

Main Results:

• MSCs possess multi-lineage potential and secrete factors that modulate immunity and enhance tissue repair.
• Current research highlights various methods for expanding MSCs, including advanced culturing techniques and bioreactor systems.
• Biomaterial platforms and microtissue-based strategies show potential for efficient MSC expansion.

Conclusions:

• Optimizing MSC expansion is key to overcoming current limitations for bone defect regeneration.
• Further research into MSC microenvironments and scalable biomanufacturing is needed.
• Advancements in expansion strategies promise to accelerate the clinical translation of MSC-based therapies for bone diseases.